MAIA Biotechnology (NYSEMKT:MAIA) just reported results for the fourth quarter of 2023.
- MAIA Biotechnology reported earnings per share of -41 cents. This was below the analyst estimate for EPS of -39 cents.
- The company did not report any revenue for the quarter.